Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: Analysis via dual parameter flow-cytometric assay

Cancer Immunology, Immunotherapy

Volumn 57, Issue 8, 2008, Pages 1137-1149

  Kondadasula, Sri Vidya ^a   Varker, Kimberly A ^a   Lesinski, Gregory B ^a   Benson Jr , Don M ^b   Lehman, Amy ^c   Olencki, Thomas ^b   Monk, J Paul ^b   Kendra, Kari ^b   Carson III, William E ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

ERK; Flow cytometry; Interleukin 2; Monocyte; Natural killer cell; T Cells

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT INTERLEUKIN 2;

ARTICLE; B LYMPHOCYTE; CANCER PATIENT; CONTROLLED STUDY; EYE CANCER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; IN VITRO STUDY; KIDNEY CARCINOMA; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 44249127297     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0444-7     Document Type: Article

References (25)

1. 1. MB Atkins L Kunkel M Sznol SA Rosenberg 2000 High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update Cancer J Sci Am 6 Suppl 1 S11 S14 10685652 Atkins MB, Kunkel L, Sznol M, Rosenberg SA (2000) High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update. Cancer J Sci Am 6(Suppl 1):S11–S14
2. 2. C Beadling KA Smith 2002 DNA array analysis of interleukin-2-regulated immediate/early genes Med Immunol 1 2 12459040 10.1186/1476-9433-1-2 Beadling C, Smith KA (2002) DNA array analysis of interleukin-2-regulated immediate/early genes. Med Immunol 1:2
3. 3. S Chow H Patel DW Hedley 2001 Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors Cytometry 46 72 78 11309815 10.1002/cyto.1067 1:CAS:528:DC%2BD3MXktVSnsrc%3D Chow S, Patel H, Hedley DW (2001) Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry 46:72–78
4. 4. GA Evans MA Goldsmith JA Johnston W Xu SR Weiler R Erwin OM Howard RT Abraham JJ O’Shea WC Greene 1995 Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association J Biol Chem 270 28858 28863 7499411 10.1074/jbc.270.48.28858 1:CAS:528:DyaK2MXpslOjtLg%3D Evans GA, Goldsmith MA, Johnston JA, Xu W, Weiler SR, Erwin R, Howard OM, Abraham RT, O’Shea JJ, Greene WC et al (1995) Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association. J Biol Chem 270:28858–28863
5. 5. SS Farag MA Caligiuri 2006 Human natural killer cell development and biology Blood Rev 20 123 137 16364519 10.1016/j.blre.2005.10.001 1:CAS:528:DC%2BD28Xlt1ejtL0%3D Farag SS, Caligiuri MA (2006) Human natural killer cell development and biology. Blood Rev 20:123–137
6. 6. F Gesbert M Delespine-Carmagnat J Bertoglio 1998 Recent advances in the understanding of interleukin-2 signal transduction J Clin Immunol 18 307 320 9793823 10.1023/A:1023223614407 1:CAS:528:DyaK1cXmvFWhur0%3D Gesbert F, Delespine-Carmagnat M, Bertoglio J (1998) Recent advances in the understanding of interleukin-2 signal transduction. J Clin Immunol 18:307–320
7. 7. JD Graves J Downward M Izquierdo-Pastor S Rayter PH Warne DA Cantrell 1992 The growth factor IL-2 activates p21ras proteins in normal human T lymphocytes J Immunol 148 2417 2422 1532814 1:CAS:528:DyaK38XktVGku74%3D Graves JD, Downward J, Izquierdo-Pastor M, Rayter S, Warne PH, Cantrell DA (1992) The growth factor IL-2 activates p21ras proteins in normal human T lymphocytes. J Immunol 148:2417–2422
8. 8. M Karin 1995 The regulation of AP-1 activity by mitogen-activated protein kinases J Biol Chem 270 16483 16486 7622446 1:CAS:528:DyaK2MXmvFOks7w%3D Karin M (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483–16486
9. 9. LM Karnitz RT Abraham 1996 Interleukin-2 receptor signaling mechanisms Adv Immunol 61 147 199 8834496 1:CAS:528:DyaK28Xis1Kqsrk%3D 10.1016/S0065-2776(08)60867-6 Karnitz LM, Abraham RT (1996) Interleukin-2 receptor signaling mechanisms. Adv Immunol 61:147–199
10. 10. GB Lesinski SV Kondadasula T Crespin L Shen K Kendra M Walker WE Carson 3rd 2004 Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy J Natl Cancer Inst 96 1331 1342 15339971 1:CAS:528:DC%2BD2cXnsVyht7k%3D 10.1093/jnci/djh252 Lesinski GB, Kondadasula SV, Crespin T, Shen L, Kendra K, Walker M, Carson WE 3rd (2004) Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. J Natl Cancer Inst 96:1331–1342
11. 11. JX Lin WJ Leonard 2000 The role of Stat5a and Stat5b in signaling by IL-2 family cytokines Oncogene 19 2566 2576 10851055 10.1038/sj.onc.1203523 1:CAS:528:DC%2BD3cXktVGhtr4%3D Lin JX, Leonard WJ (2000) The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19:2566–2576
12. 12. P Lissoni V Bordin M Vaghi L Fumagalli A Bordoni S Mengo R Bucovec E Fumagalli F Malugani A Ardizzoia L Giani GS Gardani G Tancini 2002 Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2 Anticancer Res 22 1061 1064 12168901 1:CAS:528:DC%2BD38XmsFWrsrY%3D Lissoni P, Bordin V, Vaghi M, Fumagalli L, Bordoni A, Mengo S, Bucovec R, Fumagalli E, Malugani F, Ardizzoia A, Giani L, Gardani GS, Tancini G (2002) Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2. Anticancer Res 22:1061–1064
13. 13. DF McDermott MM Regan JI Clark LE Flaherty GR Weiss TF Logan JM Kirkwood MS Gordon JA Sosman MS Ernstoff CP Tretter WJ Urba JW Smith KA Margolin JW Mier JA Gollob JP Dutcher MB Atkins 2005 Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. J Clin Oncol 23 133 141 15625368 10.1200/JCO.2005.03.206 1:CAS:528:DC%2BD2MXpslaktw%3D%3D McDermott DF, Regan MM, Clark JI, Flaherty LE, Weiss GR, Logan TF, Kirkwood JM, Gordon MS, Sosman JA, Ernstoff MS, Tretter CP, Urba WJ, Smith JW, Margolin KA, Mier JW, Gollob JA, Dutcher JP, Atkins MB (2005) Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. J Clin Oncol 23:133–141
14. 14. DT Montag MT Lotze 2006 Successful simultaneous measurement of cell membrane and cytokine induced phosphorylation pathways [CIPP] in human peripheral blood mononuclear cells J Immunol Methods 313 48 60 16716344 10.1016/j.jim.2006.03.014 1:CAS:528:DC%2BD28XmslKjs70%3D Montag DT, Lotze MT (2006) Successful simultaneous measurement of cell membrane and cytokine induced phosphorylation pathways [CIPP] in human peripheral blood mononuclear cells. J Immunol Methods 313:48–60
15. 15. BH Nelson 2004 IL-2, regulatory T cells, and tolerance J Immunol 172 3983 3988 15034008 1:CAS:528:DC%2BD2cXitlOqsrk%3D Nelson BH (2004) IL-2, regulatory T cells, and tolerance. J Immunol 172:3983-3988
16. 16. O Perola A Ripatti J Pelkonen 2000 T-lymphocyte subpopulations do not express identical combinations of interleukin-2 receptor chains in the early phase of their activation and proliferation Scand J Immunol 52 123 130 10931379 10.1046/j.1365-3083.2000.00751.x 1:CAS:528:DC%2BD3cXlvFykt7g%3D Perola O, Ripatti A, Pelkonen J (2000) T-lymphocyte subpopulations do not express identical combinations of interleukin-2 receptor chains in the early phase of their activation and proliferation. Scand J Immunol 52:123–130
17. 17. MR Ricciardi T McQueen D Chism M Milella E Estey E Kaldjian J Sebolt-Leopold M Konopleva M Andreeff 2005 Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia Leukemia 19 1543 1549 16001087 10.1038/sj.leu.2403859 1:CAS:528:DC%2BD2MXovVOjur8%3D Ricciardi MR, McQueen T, Chism D, Milella M, Estey E, Kaldjian E, Sebolt-Leopold J, Konopleva M, Andreeff M (2005) Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia. Leukemia 19:1543–1549
18. 18. MJ Robertson KJ Cochran C Cameron JM Le R Tantravahi J Ritz 1996 Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia Exp Hematol 24 406 415 8599969 1:STN:280:DyaK287otValsw%3D%3D Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J (1996) Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 24:406–415
19. 19. AE Schade AD Levine 2004 Cutting edge: extracellular signal-regulated kinases 1/2 function as integrators of TCR signal strength J Immunol 172 5828 5832 15128760 1:CAS:528:DC%2BD2cXjs1Ojtrs%3D Schade AE, Levine AD (2004) Cutting edge: extracellular signal-regulated kinases 1/2 function as integrators of TCR signal strength. J Immunol 172:5828–5832
20. 20. J Theze PM Alzari J Bertoglio 1996 Interleukin 2 and its receptors: recent advances and new immunological functions Immunol Today 17 481 486 8908814 10.1016/0167-5699(96)10057-C 1:CAS:528:DyaK28Xmt1Kjsr8%3D Theze J, Alzari PM, Bertoglio J (1996) Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol Today 17:481–486
21. 21. KA Varker SV Kondadasula MR Go GB Lesinski R Ghosh-Berkebile A Lehman JP Monk T Olencki K Kendra WE Carson 3rd 2006 Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy Clin Cancer Res 12 5850 5858 17020993 10.1158/1078-0432.CCR-06-1159 1:CAS:528:DC%2BD28XhtVartbjE Varker KA, Kondadasula SV, Go MR, Lesinski GB, Ghosh-Berkebile R, Lehman A, Monk JP, Olencki T, Kendra K, Carson WE 3rd (2006) Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy. Clin Cancer Res 12:5850–5858
22. 22. R Wisdom 1999 AP-1: one switch for many signals Exp Cell Res 253 180 185 10579922 10.1006/excr.1999.4685 1:CAS:528:DyaK1MXnsF2it78%3D Wisdom R (1999) AP-1: one switch for many signals. Exp Cell Res 253:180–185
23. 23. JC Yang RM Sherry SM Steinberg SL Topalian DJ Schwartzentruber P Hwu CA Seipp L Rogers-Freezer KE Morton DE White DJ Liewehr MJ Merino SA Rosenberg 2003 Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer J Clin Oncol 21 3127 3132 12915604 10.1200/JCO.2003.02.122 1:CAS:528:DC%2BD2cXpsVWqtb8%3D Yang JC, Sherry RM, Steinberg SM, Topalian SL, Schwartzentruber DJ, Hwu P, Seipp CA, Rogers-Freezer L, Morton KE, White DE, Liewehr DJ, Merino MJ, Rosenberg SA (2003) Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J Clin Oncol 21:3127–3132
24. 24. TK Yu EG Caudell C Smid EA Grimm 2000 IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway J Immunol 164 6244 6251 10843677 1:CAS:528:DC%2BD3cXktFWltr0%3D Yu TK, Caudell EG, Smid C, Grimm EA (2000) IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway. J Immunol 164:6244–6251
25. 25. T Zell A Khoruts E Ingulli JL Bonnevier DL Mueller MK Jenkins 2001 Single-cell analysis of signal transduction in CD4 T cells stimulated by antigen in vivo Proc Natl Acad Sci USA 98 10805 10810 11535838 10.1073/pnas.191567898 1:CAS:528:DC%2BD3MXntVGmsL0%3D Zell T, Khoruts A, Ingulli E, Bonnevier JL, Mueller DL, Jenkins MK (2001) Single-cell analysis of signal transduction in CD4 T cells stimulated by antigen in vivo. Proc Natl Acad Sci USA 98:10805–10810